APOO and Hyperglycemia: To gain further insights about the role of MIC26 regarding the differential regulation of glycolytic pathways in normoglycemia and hyperglycemia, we re-visited our transcriptomics (Fig S3) and proteomics (Figs 3A–C and J–L and S3C) datasets and investigated the genes regulating glycolysis upon MIC26 deletion.